In follow-up studies, an association analysis demonstrated a highly significant correlation between TMEM106B and PGRN plasma levels and mRNA expression, with greater statistical significance in patients with FTLD with GRN mutations [ 80 ]; these results suggested that TMEM106B expression modulates the development of FTLD through its interactions with PGRN.
← all excerpts
Recent insights into the involvement of progranulin in frontotemporal dementia.
1
—
—